Related Experiment Videos

Staged repair of interrupted aortic arch with ventricular septal defect compared with primary repair in infancy

R S Sawin1, D G Hall, P B Mansfield

  • 1Department of Surgery, Children's Hospital and Medical Center, Seattle, Washington 98105.

Insights

Interrupted aortic arch with ventricular septal defect has high mortality. Staged surgical repair in infancy offers outcomes comparable to simultaneous repair, improving survival rates for this complex congenital heart defect.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Surgical Outcomes

Background:

  • Interrupted aortic arch (IAA) is a severe congenital heart defect with high mortality.
  • Intracardiac lesions, such as ventricular septal defect (VSD), complicate IAA management.
  • Early recognition and treatment are critical for survival in IAA patients.

Purpose of the Study:

  • To evaluate the outcomes of staged surgical repair for IAA with VSD in infants.
  • To compare the results of staged repair with previously reported simultaneous repair strategies.
  • To identify factors contributing to improved survival in IAA patients.

Main Methods:

  • Retrospective review of nine infants with IAA and VSD treated between 1979 and 1987.
  • Primary repair of IAA with pulmonary artery banding in infancy.
  • Eventual repair of VSD at a later stage.
  • Analysis of operative and overall mortality rates.

Main Results:

  • Operative mortality for IAA repair was 11% (1 of 9 patients).
  • Overall mortality for the nine patients was 22% after staged VSD repair.
  • Staged repair demonstrated outcomes comparable to simultaneous repair approaches.
  • Prostaglandin E use and improved perioperative stabilization likely contributed to survival.

Conclusions:

  • Staged surgical repair of interrupted aortic arch with ventricular septal defect is a viable option.
  • This approach yields results comparable to simultaneous repair in infancy.
  • Improved perioperative care, including prostaglandin E, is crucial for better survival in complex congenital heart defects.

Related Concept Videos